COMPLETED

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

Talk to us

Conditions

Dry Eye DiseaseMeibomian Gland DysfunctionCataract SenileDry Eye Syndromes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

Official Title

The Efficacy of the Systane iLux System on Preoperative Cataract Patients on Dry Eye Disease Due to Meibomian Gland Dysfunction

Quick Facts

Study Start:2024-06-03
Study Completion:2025-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06483750

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age greater than 18 at the time of informed consent
  2. * Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
  3. * Upcoming scheduled senile cataract surgery
  1. * Eyelid abnormalities
  2. * Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
  3. * Ocular surgery within the last 6 months
  4. * Occlusion therapy with lacrimal or punctum plugs within the last 3 months
  5. * Patients with an ocular surface abnormality that may compromise corneal integrity
  6. * Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months)
  7. * Patients with cicatricial lid margin disease
  8. * patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia
  9. * Patients with permanent makeup or tattoos on their eyelids.
  10. * Previous application/administration of Systane iLux or LipiFlow treatment

Contacts and Locations

Principal Investigator

Keith Wroblewski, MD
PRINCIPAL_INVESTIGATOR
George Washington MFA

Study Locations (Sites)

George Washington University
Washington D.C., District of Columbia, 20037
United States

Collaborators and Investigators

Sponsor: George Washington University

  • Keith Wroblewski, MD, PRINCIPAL_INVESTIGATOR, George Washington MFA

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-03
Study Completion Date2025-02-01

Study Record Updates

Study Start Date2024-06-03
Study Completion Date2025-02-01

Terms related to this study

Additional Relevant MeSH Terms

  • Dry Eye Disease
  • Meibomian Gland Dysfunction
  • Cataract Senile
  • Dry Eye Syndromes